Elizabeth Bayliss
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deprescriptions | 11 | 2023 | 27 | 6.020 |
Why?
| Chronic Disease | 31 | 2023 | 1637 | 4.630 |
Why?
| Multiple Chronic Conditions | 11 | 2021 | 24 | 2.940 |
Why?
| Dementia | 8 | 2023 | 208 | 2.720 |
Why?
| Primary Health Care | 21 | 2022 | 1560 | 2.560 |
Why?
| Cognitive Dysfunction | 6 | 2023 | 301 | 2.540 |
Why?
| Comorbidity | 23 | 2018 | 1527 | 2.500 |
Why?
| Patient-Centered Care | 8 | 2021 | 497 | 2.100 |
Why?
| Patient Care Team | 9 | 2019 | 522 | 2.060 |
Why?
| Patient Portals | 4 | 2022 | 31 | 1.880 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 3 | 2023 | 246 | 1.650 |
Why?
| Delivery of Health Care, Integrated | 6 | 2021 | 233 | 1.510 |
Why?
| Quality of Life | 16 | 2022 | 2369 | 1.490 |
Why?
| Aged | 60 | 2023 | 19661 | 1.480 |
Why?
| Health Status | 8 | 2019 | 726 | 1.480 |
Why?
| Physicians, Primary Care | 7 | 2019 | 222 | 1.440 |
Why?
| Safety-net Providers | 3 | 2021 | 96 | 1.320 |
Why?
| Depressive Disorder | 4 | 2012 | 333 | 1.250 |
Why?
| Delivery of Health Care | 8 | 2021 | 869 | 1.250 |
Why?
| Continuity of Patient Care | 4 | 2019 | 265 | 1.200 |
Why?
| Self Care | 6 | 2012 | 357 | 1.120 |
Why?
| Quality of Health Care | 4 | 2021 | 586 | 1.110 |
Why?
| Aged, 80 and over | 26 | 2023 | 6562 | 1.060 |
Why?
| Mental Disorders | 6 | 2020 | 939 | 1.010 |
Why?
| Chronic Pain | 2 | 2022 | 211 | 1.010 |
Why?
| Female | 74 | 2023 | 61588 | 0.980 |
Why?
| Communication | 7 | 2022 | 761 | 0.970 |
Why?
| Male | 73 | 2023 | 57818 | 0.960 |
Why?
| Humans | 107 | 2023 | 119032 | 0.950 |
Why?
| Health Services | 2 | 2017 | 110 | 0.930 |
Why?
| Attitude of Health Personnel | 5 | 2017 | 993 | 0.920 |
Why?
| Gastric Bypass | 2 | 2014 | 93 | 0.890 |
Why?
| Health Status Indicators | 2 | 2014 | 154 | 0.850 |
Why?
| Medication Adherence | 6 | 2022 | 556 | 0.840 |
Why?
| Patient Reported Outcome Measures | 4 | 2019 | 252 | 0.810 |
Why?
| Cholinergic Antagonists | 2 | 2019 | 28 | 0.800 |
Why?
| Retrospective Studies | 29 | 2022 | 12990 | 0.790 |
Why?
| Food Supply | 1 | 2021 | 64 | 0.780 |
Why?
| Health Plan Implementation | 2 | 2019 | 133 | 0.760 |
Why?
| Mental Health Services | 3 | 2019 | 331 | 0.740 |
Why?
| United States | 30 | 2023 | 12557 | 0.740 |
Why?
| Self Efficacy | 3 | 2019 | 366 | 0.740 |
Why?
| Advance Directives | 1 | 2020 | 62 | 0.700 |
Why?
| Medicare Part D | 2 | 2010 | 25 | 0.680 |
Why?
| Qualitative Research | 10 | 2021 | 953 | 0.680 |
Why?
| Cohort Studies | 17 | 2022 | 5117 | 0.680 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1136 | 0.670 |
Why?
| Practice Guidelines as Topic | 3 | 2021 | 1440 | 0.660 |
Why?
| Middle Aged | 37 | 2021 | 27627 | 0.660 |
Why?
| Documentation | 1 | 2020 | 175 | 0.650 |
Why?
| Delayed Diagnosis | 1 | 2018 | 79 | 0.650 |
Why?
| Health Services Needs and Demand | 3 | 2015 | 254 | 0.630 |
Why?
| Diabetic Neuropathies | 2 | 2016 | 78 | 0.630 |
Why?
| Hypolipidemic Agents | 3 | 2017 | 86 | 0.620 |
Why?
| Patient Acceptance of Health Care | 4 | 2021 | 687 | 0.620 |
Why?
| Polypharmacy | 6 | 2023 | 75 | 0.610 |
Why?
| Time-to-Treatment | 1 | 2018 | 149 | 0.610 |
Why?
| Specialization | 2 | 2017 | 120 | 0.600 |
Why?
| Hospitalization | 6 | 2023 | 1785 | 0.590 |
Why?
| Healthcare Disparities | 2 | 2021 | 496 | 0.580 |
Why?
| Diabetes Mellitus, Type 2 | 7 | 2023 | 2179 | 0.570 |
Why?
| Health Maintenance Organizations | 6 | 2012 | 96 | 0.570 |
Why?
| Practice Patterns, Physicians' | 3 | 2017 | 1200 | 0.560 |
Why?
| Patient Satisfaction | 4 | 2019 | 610 | 0.560 |
Why?
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 1185 | 0.560 |
Why?
| Medicaid | 2 | 2022 | 411 | 0.550 |
Why?
| Medically Uninsured | 1 | 2017 | 125 | 0.550 |
Why?
| Adult | 31 | 2023 | 31525 | 0.550 |
Why?
| Telemedicine | 3 | 2023 | 668 | 0.540 |
Why?
| Hypoglycemic Agents | 5 | 2019 | 1035 | 0.540 |
Why?
| Colorado | 12 | 2021 | 4196 | 0.540 |
Why?
| Patients | 2 | 2021 | 175 | 0.540 |
Why?
| Antihypertensive Agents | 5 | 2019 | 438 | 0.530 |
Why?
| Bariatric Surgery | 2 | 2015 | 166 | 0.530 |
Why?
| Pain Management | 2 | 2015 | 293 | 0.520 |
Why?
| Caregivers | 9 | 2023 | 709 | 0.520 |
Why?
| Health Promotion | 1 | 2021 | 691 | 0.520 |
Why?
| Sickness Impact Profile | 2 | 2005 | 51 | 0.520 |
Why?
| Surveys and Questionnaires | 17 | 2022 | 4709 | 0.510 |
Why?
| Gastroplasty | 1 | 2014 | 26 | 0.510 |
Why?
| Potentially Inappropriate Medication List | 3 | 2023 | 14 | 0.500 |
Why?
| Electronic Health Records | 3 | 2021 | 830 | 0.500 |
Why?
| Health Services Accessibility | 3 | 2017 | 781 | 0.500 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2015 | 102 | 0.490 |
Why?
| Diabetes Mellitus | 7 | 2017 | 945 | 0.490 |
Why?
| Focus Groups | 5 | 2020 | 387 | 0.490 |
Why?
| Hypertension | 7 | 2019 | 1203 | 0.470 |
Why?
| Neuralgia | 1 | 2015 | 120 | 0.470 |
Why?
| Drug Utilization | 2 | 2012 | 169 | 0.470 |
Why?
| Laparoscopy | 2 | 2014 | 418 | 0.460 |
Why?
| Colorectal Neoplasms | 3 | 2014 | 628 | 0.460 |
Why?
| Postoperative Care | 1 | 2015 | 237 | 0.460 |
Why?
| Socioeconomic Factors | 7 | 2020 | 1129 | 0.460 |
Why?
| Morbidity | 2 | 2012 | 296 | 0.460 |
Why?
| Sleep Deprivation | 1 | 2015 | 164 | 0.460 |
Why?
| Comparative Effectiveness Research | 1 | 2014 | 132 | 0.450 |
Why?
| Preoperative Care | 1 | 2015 | 332 | 0.440 |
Why?
| Morphine | 1 | 2013 | 134 | 0.430 |
Why?
| Cross-Sectional Studies | 14 | 2023 | 4552 | 0.430 |
Why?
| Referral and Consultation | 1 | 2017 | 648 | 0.420 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2012 | 37 | 0.410 |
Why?
| Osteoarthritis | 3 | 2008 | 176 | 0.410 |
Why?
| Cluster Analysis | 2 | 2020 | 481 | 0.400 |
Why?
| International Classification of Diseases | 1 | 2012 | 122 | 0.390 |
Why?
| Antidepressive Agents | 1 | 2012 | 189 | 0.390 |
Why?
| Severity of Illness Index | 3 | 2015 | 2674 | 0.390 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 387 | 0.390 |
Why?
| Quality Improvement | 5 | 2020 | 963 | 0.390 |
Why?
| Obesity | 2 | 2014 | 2751 | 0.380 |
Why?
| Office Visits | 3 | 2018 | 83 | 0.380 |
Why?
| Psychotherapy | 1 | 2012 | 177 | 0.380 |
Why?
| Prostatic Neoplasms | 2 | 2014 | 940 | 0.380 |
Why?
| Self Report | 5 | 2023 | 699 | 0.370 |
Why?
| Physician-Patient Relations | 6 | 2019 | 489 | 0.370 |
Why?
| Models, Statistical | 1 | 2014 | 636 | 0.360 |
Why?
| Multimorbidity | 2 | 2021 | 29 | 0.360 |
Why?
| Neoplasms | 3 | 2014 | 2179 | 0.360 |
Why?
| Patient Preference | 3 | 2022 | 170 | 0.360 |
Why?
| Perception | 3 | 2020 | 314 | 0.350 |
Why?
| Vaccination Refusal | 2 | 2021 | 69 | 0.350 |
Why?
| Analgesics, Opioid | 2 | 2014 | 793 | 0.350 |
Why?
| Patient Participation | 5 | 2022 | 369 | 0.350 |
Why?
| Emergency Service, Hospital | 3 | 2015 | 1864 | 0.340 |
Why?
| Medicare | 6 | 2023 | 665 | 0.340 |
Why?
| Stakeholder Participation | 2 | 2020 | 69 | 0.340 |
Why?
| Research | 3 | 2018 | 411 | 0.340 |
Why?
| Delphi Technique | 4 | 2018 | 164 | 0.330 |
Why?
| Risk Assessment | 7 | 2020 | 3057 | 0.330 |
Why?
| Depressive Disorder, Major | 1 | 2012 | 303 | 0.330 |
Why?
| Health Personnel | 3 | 2019 | 588 | 0.330 |
Why?
| Disease Progression | 2 | 2015 | 2490 | 0.310 |
Why?
| Health Services for the Aged | 1 | 2008 | 71 | 0.310 |
Why?
| Geriatrics | 1 | 2008 | 68 | 0.310 |
Why?
| Cost of Illness | 2 | 2008 | 258 | 0.300 |
Why?
| Glomerular Filtration Rate | 1 | 2011 | 684 | 0.300 |
Why?
| Breast Neoplasms | 1 | 2018 | 1965 | 0.290 |
Why?
| Psychometrics | 3 | 2018 | 631 | 0.290 |
Why?
| Kidney Diseases | 1 | 2011 | 442 | 0.280 |
Why?
| Accidental Falls | 2 | 2019 | 154 | 0.280 |
Why?
| Telephone | 2 | 2017 | 152 | 0.270 |
Why?
| Parents | 3 | 2021 | 1212 | 0.250 |
Why?
| Pain Measurement | 2 | 2018 | 469 | 0.250 |
Why?
| Patient Compliance | 1 | 2008 | 537 | 0.250 |
Why?
| Disease Management | 4 | 2017 | 571 | 0.250 |
Why?
| Cardiovascular Diseases | 2 | 2014 | 1802 | 0.250 |
Why?
| Nomograms | 2 | 2014 | 48 | 0.250 |
Why?
| Single-Payer System | 1 | 2003 | 2 | 0.240 |
Why?
| National Health Insurance, United States | 1 | 2003 | 5 | 0.240 |
Why?
| Pragmatic Clinical Trials as Topic | 2 | 2022 | 49 | 0.240 |
Why?
| Death | 2 | 2022 | 105 | 0.240 |
Why?
| Dyslipidemias | 3 | 2019 | 162 | 0.240 |
Why?
| Managed Care Programs | 2 | 2014 | 135 | 0.240 |
Why?
| Vaccination | 3 | 2021 | 1223 | 0.240 |
Why?
| Multivariate Analysis | 5 | 2013 | 1474 | 0.230 |
Why?
| Health Services Research | 3 | 2017 | 385 | 0.230 |
Why?
| Inappropriate Prescribing | 1 | 2023 | 52 | 0.220 |
Why?
| Insurance Coverage | 2 | 2018 | 208 | 0.220 |
Why?
| Prognosis | 4 | 2014 | 3443 | 0.220 |
Why?
| Interdisciplinary Communication | 2 | 2014 | 191 | 0.220 |
Why?
| Attitude | 2 | 2021 | 231 | 0.220 |
Why?
| Health Care Reform | 1 | 2003 | 95 | 0.220 |
Why?
| Data Collection | 1 | 2005 | 658 | 0.220 |
Why?
| Asthma | 2 | 2016 | 2159 | 0.210 |
Why?
| Physicians | 2 | 2023 | 794 | 0.210 |
Why?
| Survival Rate | 3 | 2014 | 1720 | 0.210 |
Why?
| Proxy | 1 | 2021 | 22 | 0.200 |
Why?
| Maryland | 1 | 2020 | 36 | 0.190 |
Why?
| Longitudinal Studies | 4 | 2018 | 2513 | 0.190 |
Why?
| Information Storage and Retrieval | 1 | 2021 | 124 | 0.190 |
Why?
| Patient Care Management | 1 | 2020 | 57 | 0.190 |
Why?
| Age Factors | 6 | 2019 | 2995 | 0.190 |
Why?
| Clergy | 1 | 2020 | 13 | 0.180 |
Why?
| Fee-for-Service Plans | 2 | 2014 | 79 | 0.180 |
Why?
| Health Surveys | 3 | 2012 | 454 | 0.180 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.180 |
Why?
| Pharmaceutical Preparations | 1 | 2022 | 168 | 0.180 |
Why?
| Child, Preschool | 5 | 2021 | 9493 | 0.180 |
Why?
| Residence Characteristics | 1 | 2022 | 299 | 0.180 |
Why?
| Southwestern United States | 1 | 2019 | 94 | 0.180 |
Why?
| Follow-Up Studies | 4 | 2017 | 4596 | 0.170 |
Why?
| Urban Health Services | 1 | 2019 | 60 | 0.170 |
Why?
| Interprofessional Relations | 2 | 2013 | 262 | 0.170 |
Why?
| Religion | 1 | 2019 | 68 | 0.170 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 44 | 0.170 |
Why?
| Time Factors | 5 | 2018 | 6414 | 0.170 |
Why?
| Attitude to Health | 2 | 2015 | 410 | 0.170 |
Why?
| Comprehensive Health Care | 2 | 2017 | 20 | 0.170 |
Why?
| Contraindications, Drug | 1 | 2018 | 7 | 0.160 |
Why?
| Mastectomy | 1 | 2018 | 124 | 0.160 |
Why?
| Radiotherapy, Adjuvant | 1 | 2018 | 189 | 0.160 |
Why?
| Young Adult | 6 | 2016 | 10799 | 0.160 |
Why?
| Vaccines | 2 | 2020 | 380 | 0.160 |
Why?
| Medical Informatics | 1 | 2019 | 102 | 0.160 |
Why?
| Interviews as Topic | 3 | 2016 | 599 | 0.160 |
Why?
| Prospective Studies | 5 | 2023 | 6477 | 0.150 |
Why?
| Chemotherapy, Adjuvant | 1 | 2018 | 360 | 0.150 |
Why?
| Models, Theoretical | 1 | 2021 | 556 | 0.150 |
Why?
| Independent Living | 1 | 2018 | 87 | 0.150 |
Why?
| SEER Program | 2 | 2014 | 205 | 0.150 |
Why?
| General Practice | 1 | 2016 | 26 | 0.140 |
Why?
| Case Management | 1 | 2017 | 63 | 0.140 |
Why?
| Adolescent | 6 | 2015 | 18483 | 0.140 |
Why?
| Logistic Models | 5 | 2013 | 1901 | 0.140 |
Why?
| Blood Pressure | 3 | 2019 | 1664 | 0.140 |
Why?
| Electronics | 1 | 2017 | 76 | 0.140 |
Why?
| Body Mass Index | 2 | 2014 | 2092 | 0.140 |
Why?
| Schools | 1 | 2019 | 411 | 0.140 |
Why?
| Influenza Vaccines | 1 | 2021 | 501 | 0.140 |
Why?
| Medication Therapy Management | 1 | 2017 | 72 | 0.140 |
Why?
| Patient Outcome Assessment | 1 | 2017 | 122 | 0.140 |
Why?
| Validation Studies as Topic | 1 | 2015 | 21 | 0.140 |
Why?
| Health Care Costs | 1 | 2019 | 394 | 0.130 |
Why?
| Metformin | 1 | 2019 | 295 | 0.130 |
Why?
| Infant | 2 | 2021 | 8295 | 0.130 |
Why?
| Clinical Decision-Making | 1 | 2018 | 277 | 0.130 |
Why?
| Influenza, Human | 1 | 2021 | 555 | 0.130 |
Why?
| Neoplasm Staging | 1 | 2018 | 1223 | 0.130 |
Why?
| Hyperlipidemias | 2 | 2012 | 128 | 0.120 |
Why?
| United States Agency for Healthcare Research and Quality | 1 | 2014 | 9 | 0.120 |
Why?
| Proportional Hazards Models | 2 | 2015 | 1125 | 0.120 |
Why?
| Research Design | 1 | 2020 | 969 | 0.120 |
Why?
| Child | 5 | 2021 | 19137 | 0.120 |
Why?
| Health Priorities | 1 | 2014 | 34 | 0.120 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2022 | 765 | 0.120 |
Why?
| Health Education | 1 | 2016 | 318 | 0.120 |
Why?
| Activities of Daily Living | 2 | 2008 | 355 | 0.120 |
Why?
| Cooperative Behavior | 2 | 2014 | 408 | 0.120 |
Why?
| Age Distribution | 1 | 2014 | 362 | 0.110 |
Why?
| Risk Factors | 6 | 2023 | 9003 | 0.110 |
Why?
| Decision Making | 1 | 2019 | 809 | 0.110 |
Why?
| Depression | 3 | 2018 | 1137 | 0.110 |
Why?
| Postoperative Complications | 2 | 2014 | 2235 | 0.110 |
Why?
| Terminally Ill | 1 | 2013 | 33 | 0.110 |
Why?
| Lung Diseases, Obstructive | 1 | 2012 | 44 | 0.110 |
Why?
| Postoperative Period | 1 | 2013 | 309 | 0.110 |
Why?
| Guideline Adherence | 1 | 2017 | 523 | 0.110 |
Why?
| Program Evaluation | 1 | 2017 | 845 | 0.110 |
Why?
| Information Dissemination | 1 | 2014 | 210 | 0.110 |
Why?
| Obesity, Morbid | 1 | 2014 | 197 | 0.100 |
Why?
| Insulin | 2 | 2019 | 2170 | 0.100 |
Why?
| Quality Assurance, Health Care | 1 | 2014 | 325 | 0.100 |
Why?
| Secondary Prevention | 1 | 2013 | 227 | 0.100 |
Why?
| Diabetes Complications | 1 | 2013 | 219 | 0.100 |
Why?
| Primary Prevention | 1 | 2013 | 185 | 0.100 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 131 | 0.090 |
Why?
| Data Mining | 1 | 2011 | 113 | 0.090 |
Why?
| Weight Loss | 1 | 2015 | 658 | 0.090 |
Why?
| Osteoarthritis, Knee | 1 | 2013 | 223 | 0.090 |
Why?
| Emigrants and Immigrants | 1 | 2012 | 115 | 0.090 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 693 | 0.090 |
Why?
| Databases, Factual | 2 | 2012 | 1231 | 0.090 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2013 | 247 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2019 | 2874 | 0.090 |
Why?
| Prescription Fees | 1 | 2008 | 3 | 0.080 |
Why?
| Medical Records Systems, Computerized | 2 | 2007 | 92 | 0.080 |
Why?
| Poisson Distribution | 1 | 2008 | 68 | 0.080 |
Why?
| Autoimmune Diseases | 1 | 2012 | 398 | 0.080 |
Why?
| Self Disclosure | 1 | 2008 | 60 | 0.080 |
Why?
| Drug Utilization Review | 1 | 2008 | 60 | 0.080 |
Why?
| Treatment Outcome | 4 | 2016 | 9346 | 0.080 |
Why?
| Eligibility Determination | 1 | 2008 | 55 | 0.080 |
Why?
| Pain | 1 | 2014 | 736 | 0.080 |
Why?
| Community Health Services | 1 | 2010 | 212 | 0.080 |
Why?
| Incidence | 2 | 2014 | 2424 | 0.080 |
Why?
| Biomedical Research | 1 | 2014 | 612 | 0.080 |
Why?
| Insurance, Pharmaceutical Services | 1 | 2007 | 21 | 0.080 |
Why?
| Immunoglobulin G | 1 | 2012 | 788 | 0.080 |
Why?
| Treatment Refusal | 1 | 2007 | 86 | 0.070 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 417 | 0.070 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3361 | 0.070 |
Why?
| Sex Distribution | 1 | 2007 | 351 | 0.070 |
Why?
| Odds Ratio | 3 | 2014 | 996 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2012 | 648 | 0.070 |
Why?
| Mass Screening | 1 | 2013 | 1052 | 0.070 |
Why?
| Urban Population | 2 | 2012 | 409 | 0.070 |
Why?
| California | 2 | 2020 | 382 | 0.070 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1285 | 0.070 |
Why?
| Linear Models | 1 | 2007 | 827 | 0.060 |
Why?
| Chicago | 1 | 2004 | 45 | 0.060 |
Why?
| Los Angeles | 1 | 2004 | 60 | 0.060 |
Why?
| Boston | 1 | 2004 | 76 | 0.060 |
Why?
| Pandemics | 2 | 2023 | 1355 | 0.060 |
Why?
| Algorithms | 1 | 2011 | 1543 | 0.060 |
Why?
| Self Concept | 1 | 2005 | 215 | 0.060 |
Why?
| Choice Behavior | 1 | 2005 | 160 | 0.060 |
Why?
| Goals | 1 | 2005 | 167 | 0.060 |
Why?
| Social Support | 1 | 2007 | 542 | 0.060 |
Why?
| Medicine | 1 | 2004 | 106 | 0.050 |
Why?
| Regression Analysis | 1 | 2004 | 984 | 0.050 |
Why?
| Internet | 2 | 2019 | 633 | 0.050 |
Why?
| Cholesterol, LDL | 2 | 2014 | 317 | 0.050 |
Why?
| Insurance Claim Review | 1 | 2021 | 67 | 0.050 |
Why?
| Washington | 1 | 2021 | 141 | 0.050 |
Why?
| Housing | 1 | 2022 | 123 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2012 | 525 | 0.050 |
Why?
| Health Expenditures | 1 | 2022 | 174 | 0.050 |
Why?
| Health Care Rationing | 1 | 2020 | 48 | 0.050 |
Why?
| Medical Records | 1 | 2021 | 163 | 0.050 |
Why?
| Resource Allocation | 1 | 2020 | 38 | 0.050 |
Why?
| Assisted Living Facilities | 1 | 2020 | 10 | 0.050 |
Why?
| Minority Groups | 1 | 2022 | 237 | 0.050 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 115 | 0.050 |
Why?
| Heart Failure | 1 | 2012 | 1968 | 0.040 |
Why?
| Social Determinants of Health | 1 | 2021 | 129 | 0.040 |
Why?
| Health Behavior | 1 | 2005 | 720 | 0.040 |
Why?
| Nursing Homes | 1 | 2020 | 130 | 0.040 |
Why?
| Stress, Psychological | 1 | 2007 | 976 | 0.040 |
Why?
| Appointments and Schedules | 1 | 2019 | 78 | 0.040 |
Why?
| Mortality | 1 | 2020 | 299 | 0.040 |
Why?
| Medicare Part C | 1 | 2019 | 25 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 775 | 0.040 |
Why?
| Intention | 1 | 2019 | 142 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 270 | 0.040 |
Why?
| Fatigue | 1 | 2018 | 297 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2019 | 965 | 0.030 |
Why?
| Automation | 1 | 2016 | 77 | 0.030 |
Why?
| Guidelines as Topic | 1 | 2018 | 262 | 0.030 |
Why?
| Drug Interactions | 1 | 2017 | 352 | 0.030 |
Why?
| Prevalence | 1 | 2022 | 2326 | 0.030 |
Why?
| Consensus | 1 | 2018 | 534 | 0.030 |
Why?
| Hospitals | 1 | 2020 | 601 | 0.030 |
Why?
| Sleep Wake Disorders | 1 | 2018 | 241 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 554 | 0.030 |
Why?
| Patient Access to Records | 1 | 2013 | 20 | 0.030 |
Why?
| Analysis of Variance | 2 | 2007 | 1295 | 0.030 |
Why?
| ROC Curve | 1 | 2014 | 473 | 0.030 |
Why?
| Mental Health | 1 | 2018 | 568 | 0.030 |
Why?
| Electronic Mail | 1 | 2013 | 55 | 0.030 |
Why?
| Remote Consultation | 1 | 2013 | 39 | 0.030 |
Why?
| Turkey | 1 | 2012 | 15 | 0.030 |
Why?
| Etanercept | 1 | 2012 | 51 | 0.030 |
Why?
| Biomarkers | 2 | 2013 | 3590 | 0.030 |
Why?
| Forecasting | 1 | 2014 | 354 | 0.030 |
Why?
| London | 1 | 2012 | 42 | 0.030 |
Why?
| Anxiety | 1 | 2018 | 846 | 0.030 |
Why?
| Needs Assessment | 1 | 2014 | 327 | 0.030 |
Why?
| Infliximab | 1 | 2012 | 94 | 0.030 |
Why?
| Cross-Cultural Comparison | 1 | 2012 | 81 | 0.030 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2012 | 147 | 0.030 |
Why?
| United Kingdom | 1 | 2012 | 236 | 0.020 |
Why?
| Reoperation | 1 | 2013 | 557 | 0.020 |
Why?
| Immunologic Factors | 1 | 2012 | 225 | 0.020 |
Why?
| Antirheumatic Agents | 1 | 2012 | 254 | 0.020 |
Why?
| Risk | 1 | 2012 | 854 | 0.020 |
Why?
| Models, Organizational | 1 | 2010 | 146 | 0.020 |
Why?
| Sex Characteristics | 1 | 2014 | 671 | 0.020 |
Why?
| Aging | 1 | 2018 | 1677 | 0.020 |
Why?
| Empathy | 1 | 2010 | 142 | 0.020 |
Why?
| Patient Readmission | 1 | 2013 | 633 | 0.020 |
Why?
| Holistic Health | 1 | 2007 | 5 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1175 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1781 | 0.020 |
Why?
| Veterans | 1 | 2017 | 1213 | 0.020 |
Why?
| Learning | 1 | 2010 | 374 | 0.020 |
Why?
| CD-ROM | 1 | 2005 | 7 | 0.020 |
Why?
| Diet, Fat-Restricted | 1 | 2005 | 76 | 0.020 |
Why?
| Computer-Assisted Instruction | 1 | 2005 | 66 | 0.020 |
Why?
| Nonlinear Dynamics | 1 | 2005 | 89 | 0.020 |
Why?
| Registries | 1 | 2012 | 1810 | 0.020 |
Why?
| Patient Care Planning | 1 | 2005 | 143 | 0.020 |
Why?
| Fruit | 1 | 2005 | 130 | 0.020 |
Why?
| Vegetables | 1 | 2005 | 133 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2005 | 699 | 0.010 |
Why?
| Exercise | 1 | 2005 | 1657 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|